Cargando…
Vancomycin relieves mycophenolate mofetil–induced gastrointestinal toxicity by eliminating gut bacterial β-glucuronidase activity
Mycophenolate mofetil (MMF) is commonly prescribed and has proven advantages over other immunosuppressive drugs. However, frequent gastrointestinal side effects through an unknown mechanism limit its use. We have found that consumption of MMF alters the composition of the gut microbiota, selecting f...
Autores principales: | Taylor, Michael R., Flannigan, Kyle L., Rahim, Hannah, Mohamud, Amina, Lewis, Ian A., Hirota, Simon A., Greenway, Steven C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6685722/ https://www.ncbi.nlm.nih.gov/pubmed/31457102 http://dx.doi.org/10.1126/sciadv.aax2358 |
Ejemplares similares
-
Mycophenolate mofetil alters the antioxidant status in duodenum of rats: Implication for silymarin usage in mycophenolate mofetil-induced gastrointestinal disorders
por: Sheikhzadeh, Sanaz, et al.
Publicado: (2013) -
Is Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium Justifiable for Gastrointestinal Quality of Life?
por: Gardiner, Kyle M., et al.
Publicado: (2018) -
Mycophenolate mofetil/prednisone/sirolimus: Various toxicities: case report
Publicado: (2020) -
Silymarin attenuates mycophenolate mofetil-induced duodenal disorders in rats
por: Malekinejad, Hassan, et al.
Publicado: (2014) -
Sites of gastrointestinal lesion induced by mycophenolate mofetil: a comparison with enteric-coated mycophenolate sodium in rats
por: Jia, Yichen, et al.
Publicado: (2018)